assessed the anti‐tumor efficacy of an IL‐24 delivered using vaccinia virus (Guang9 strain harboring IL‐24; VG9‐IL‐24) and showed dose‐dependent cytotoxicity in colorectal cancer cell lines. This evidence concerns the gene IL24 and colorectal cancer.